Neuropsychopharmacology
- Is the stereoisomer R-MDMA a safer version of MDMA?2 years ago
- Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy2 years ago
- Deep phenotyping reveals CRH and FKBP51-dependent behavioral profiles following chronic social stress exposure in male mice2 years ago
- NPP Editorial: tides of progress2 years ago
- Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats2 years ago
- Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study2 years ago
- PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement2 years ago
Journal of Psychopharmacology
- Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness4 years ago
- Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective4 years ago
- A unified model of ketamine’s dissociative and psychedelic properties4 years ago
- Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder4 years ago
- Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults4 years ago
- Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption4 years ago
- Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial4 years ago
European Neuropsychopharmacology
- Defining cannabis risky use: Building the plane while you fly it3 years ago
- Premise, promise and challenges of MDMA assisted therapy for PTSD3 years ago
- Robotics in psychiatry – Fiction or reality?3 years ago
- Improving drug development in precision psychiatry by ameliorating cognitive biases3 years ago
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?3 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence3 years ago
- Treating major depressive disorder with mixed features3 years ago